Andrew Lees

PhD

Speciality: CEO/CSO
Company: Fina Biosolutions
Designation: CEO/CSO

Personal Information

Dr. Andrew Lees, founder and Chief Scientific Officer of Fina Biosolutions, holds over 20 patents and is the author or co-author of more than 60 peer-reviewed papers. He holds a B.S. in Chemistry from Harvey Mudd College and a Ph.D. in Biophysics from The Johns Hopkins University. GlaxoSmithKline, the Serum Institute of India, the Chengdu Institute of Biological Products, and others all use conjugation chemistry (CDAP) developed by Dr. Lees in their S. pneumonia and meningococcal conjugate vaccines.

Dr. Lees is also an associate professor at the University of Maryland School of Medicine’s Center for Vaccine Development, an affiliate at the University of Maryland Bioprocessing Scale-Up Facility, and an adjunct professor in the Department of Medicine at the Uniformed Services University. He teaches protein chromatography through the post-graduate level, and is a frequent speaker on conjugation chemistry and biotech entrepreneurship.

Scientia Meetings

Connecting Minds for Scientific Progress!

Join us in revolutionizing conferences! Scientia Meetings is launching events across the country, offering a unique platform for scientists and researchers to share knowledge, explore innovative ideas, and foster collaborations. Buy Ticket

Clients

Our Official
Sponsors

Our curated gatherings ensure purposeful networking, creating opportunities tailored to your needs. Let's shape the future together—where knowledge connects, opportunities arise, and science thrives!

Buy Ticket